Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin

British Journal of Cancer

Volumn 106, Issue 7, 2012, Pages 1288-1296

  Garcia Santos G ^a,b   Martin, V ^a,b   Rodriguez Blanco J ^a   Herrera, F ^c   Casado Zapico, S ^a,b   Sanchez Sanchez A M ^a,b   Antolin I ^a   Rodriguez C ^a,b  

^a UNIVERSIDAD DE OVIEDO   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

apoptosis; ESFT cell lines; Fas Fas L upregulation; melatonin

Indexed keywords

CASPASE 3; FAS ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; MELATONIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; EWING SARCOMA; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; OXIDATION REDUCTION STATE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SARCOMA CELL; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD95; CELL DEATH; CELL LINE, TUMOR; FAS LIGAND PROTEIN; HUMANS; INDOLES; MELATONIN; NF-KAPPA B; REACTIVE OXYGEN SPECIES; SARCOMA, EWING; UP-REGULATION;

EID: 84859213386     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.66     Document Type: Article

References (47)

1. Abadie A, Besancon F, Wietzerbin J (2004) Type I interferon and TNFa cooperate with type II interferon for TRAIL induction and triggering of apoptosis in SK-N-MC Ewing tumor cells. Oncogene 23: 4911-4920 (Pubitemid 38932163)
2. Antolín I, Mayo JC, Sainz RM, del Brío MA, Herrera F, Martín V, Rodriguez C (2002) Protective effect of melatonin in a chronic experimental model of Parkinson's disease. Brain Res 943: 163-173 (Pubitemid 36120376)
3. Bruck R, Aeed H, Avni Y, Shirin H, Matas Z, Shahmurov M (2004) Melatonin inhibits nuclear factor kappa B activation and oxidative stress and protects thioacetamide induced liver damage in rats. J Hepatol 40: 86-93 (Pubitemid 38064716)
4. Buyukavci M, Ozdemir O, Buck S, Stout M, Ravindranath Y, Savasan S (2006) Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect. Fundam Clin Pharmacol 20: 73-79
5. Casado-Zapico S, Martin V, García-Santos G, Rodriguez-Blanco J, Sánchez-Sánchez AM, Luño E, Antolin I, Rodriguez C (2011) Regulation of the expressión of death receptors and their ligands by melatonin in haematological cancer cell lines and in leukaemia cells from patients. J Pineal Res 50: 345-355
6. Casado-Zapico S, Rodriguez-Blanco J, García-Santos G, Martin V, Sánchez-Sánchez AM, Antolín I, Rodriguez C (2010) Synergistic antitumor effect of melatonin with several chemotherapeutic drug son human Swing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway. J Pineal Res 48: 72-80
7. Chan H, Bartos DP, Owen-Schaub LB (1999) Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappa B p50-65 recruitment. Mol Cell Biol 19: 2098-2108 (Pubitemid 29098268)
8. Chuang JI, Mohan N, Meltz ML, Reiter RJ (1996) Effect of melatonin on NF-kappa-B DNA-binding activity in the rat spleen. Cell Biol Int 20: 687-692 (Pubitemid 26402163)
9. Damron TA, Ward WG, Stewart A (2007) Osteosarcoma, chondrosarcoma, and Ewing's's sarcoma: National Cancer Data Base Report. Clin Orthop Relat Res 459: 40-47 (Pubitemid 46878192)
10. de Alava E, Gerald WL (2000) Molecular biology of the Ewing's sarcoma/primitive neuroectodermal tumor family. J Clin Oncol 18: 204-213 (Pubitemid 30036354)
11. Devadas S, Hinshaw JA, Zaritskaya L, Williams MS (2003) Fas-stimulated generation of reactive oxygen species or exogenous oxidative stress sensitize cells to Fas-mediated apoptosis. Free Radical Biol Med 35: 648-661 (Pubitemid 37101132)
12. Dignam JD, Lebovitz RM, Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489
13. Friesen C, Herr I, Krammer PH, Debatin KM (1996) Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukaemia cells. Nat Med 2: 574-577 (Pubitemid 26150685)
14. Fulda S, Debatin K-M (2006) Extrinsic vs intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25: 4798-4811 (Pubitemid 44187627)
15. Fulda S, Strauss G, Meyer E, Debatin KM (2000) Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells. Blood 95: 301-308 (Pubitemid 30017256)
16. Garcia-Santos G, Antolin I, Herrera F, Martin V, Rodriguez-Blanco J, Carrera MP, Rodriguez C (2006) Melatonin induces apoptosis in human neuroblastoma cancer cells. J Pineal Res 41: 130-135 (Pubitemid 44141747)
17. Hayden MS, Ghosh S (2004) Signaling to NF-kappaB. Genes Dev 18: 2195-2224
18. Herrera F, Martin V, García-Santos G, Rodríguez-Blanco J, Antolín I, Rodríguez C (2007) Melatonin prevents glutamate-induced oxytosis in the HT22 mouse hippocampal cell line through an antioxidant effect specifically targeting mitochondria. J Neurochem 100: 736-746 (Pubitemid 46095623)
19. Hill SM, Blask DE (1988) Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 48: 6121-6126 (Pubitemid 18266811)
20. Kontny HU, Hammerle K, Klein R, Shayan P, Mackall CL, Niemeyer CM (2001) Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis. Cell Death Differ 8: 506-514 (Pubitemid 32492771)
21. Kumar A, Jasmin A, Eby MT, Chaudhary PM (2001) Cytotoxicity of tumor necrosis factor related apoptosis-inducing ligand towards Ewing's's sarcoma cell lines. Oncogene 20: 1010-1014 (Pubitemid 32207119)
22. Kwon SH, Ahn SH, Kim YK, Bae GU, Yoon JW, Hong S (2002) Apicidin, a histone deacetylase inhibitor, induces apoptosis and Fas/Fas ligand expression in human acute promyelocytic leukaemia cells. J Biol Chem 277: 2073-2080 (Pubitemid 34968790)
23. Lee MW, Park SC, Kim J-H, Kim I-K, Han KS, Kim KY, Lee WB, Jung Y-K, Kim SS (2002) The involvement of oxidative stress in tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in HeLa cells. Cancer Lett 182: 75-82 (Pubitemid 34518659)
24. Lissoni P, Barni S, Mandala M, Ardizzoia A, Paolorossi F, Vaghi M (1999) Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur J Cancer 35: 1688-1692 (Pubitemid 30050641)
25. Liu WH, Chang LS (2009) Arachidonic acid induces Fas and Fas L upregulation in human leukaemia U937 cells via Ca2 +ROS-mediated suppression of ERK/c-Fos pathway and activation of p38 MAPK/ATF-2 pathway. Toxicol Lett 191: 140-148
26. Martin V, García-santos G, Rodriguez-Blanco J, Casado-Zapico S, Sánchez-Sánchez AM, Antolin I, Medina M, Rodriguez C (2010) Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death. Cancer Lett 287: 216-223
27. Martin V, Herrera F, Carrera-Gonzalez P, García-Santos G, Antolín I, Rodríguez-Blanco J, Rodriguez C (2006) Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin. Cancer Res 66: 1081-1088 (Pubitemid 43165976)
28. Martin-Renedo J, Mauriz JL, Jorquera F, Ruiz-Andres O, Gonzalez P, Gonzalez-Gallego J (2008) Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J Pineal Res 45: 532-540
29. Merchant MS, Yang X, Melchionda F, Romero M, Klein R, Thiele CJ (2004) Interferon g enhances the effectiveness of tumor necrosis factor-related apoptosis-inducing ligand receptor agonists in a xenograft model of Ewing's sarcoma. Cancer Res 64: 8349-8356 (Pubitemid 39491774)
30. Micheau O, Solary E, Hammann A, Martin F, Dimanche-Boitrel MT (1997) Sensitization of cancer cells treated with cytotoxic drugs to Fas-mediated cytotoxicity. J Natl Cancer Inst 89: 783-789 (Pubitemid 27242279)
31. Mitsiades N, Poulaki V, Leone A, Tsokos M (1999) Fas-mediated apoptosis in Ewing's sarcoma cell lines by metalloproteinase inhibitors. J Natl Cancer Inst 91: 1678-1684 (Pubitemid 29479936)
32. Mitsiades N, Poulaki V, Mitsiades C, Tsokos M (2001) Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosisinducing ligand and express death receptor 4 and death receptor 5. Cancer Res 61: 2704-2712 (Pubitemid 32685858)
33. Osseni RA, Rat P, Bogdan A, Warnet JM, Touitou Y (2000) Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2. Life Sci 68: 387-399 (Pubitemid 32011892)
34. Picarda G, Lamoureux F, Geffroy L, Delepine P, Montier T, Laud K (2010) Preclinical evidence that use of TRAIL in Ewing's0s sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival. Clin Cancer Res 16: 2363-2374
35. Post A, Holsboer F, Behl C (1998) Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants. J Neurosci 18: 8236-8246 (Pubitemid 28465001)
36. Reis-Sobreiro M, Gajate C, Mollinedo F (2009) Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions. Oncogene 28: 3221-3224
37. Reiter RJ (2004) Mechanism of cancer inhibition by melatonin. J Pineal Res 37: 213-214
38. Reiter RJ, Tan DX, Mayo JC, Sainz RM, Leon J, Czarnocki Z (2003) Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans. Acta Biochim Pol 50: 1129-1146 (Pubitemid 38608841)
39. Rubio S, Estevez F, Cabrera J, Reiter RJ, Loro J, Quintana J (2007) Inhibition of proliferation and induction of apoptosis by melatonin in human myeloid HL-60 cells. J Pineal Res 42: 131-138 (Pubitemid 46233058)
40. Sainz RM, Mayo JC, Rodriguez C, Tan DX, Lopez-Burillo S, Reiter RJ (2003) Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci 60: 1407-1426 (Pubitemid 36900523)
41. Sato T, Machida T, Takahashi S, Iyama S, Sato Y, Kuribayashi K, Takada K, Oku T, Kawano Y, Okamoto T, Takimoto R, Matsunaga T, Takayama T, Takahashi M, Kato J, Niitsu Y (2004) Fas-mediated apoptosome formation is dependent on reactive oxygen species derived from mitochondrial permeability transition in Jurkat cells. J Immunol 173: 285-296 (Pubitemid 38797353)
42. Schoonbroodt S, Piette J (2000) Oxidative stress interference with the nuclear factor-kappa B activation pathways. Biochem Pharmacol 60: 1075-1083
43. Shen MM, Pervaiz S (2006) TNF receptor superfamily-induced cell death: redox-dependent execution. FASEB J 20: 1589-1598 (Pubitemid 44943796)
44. Starace D, Riccioli A, D'Alessio A, Giampietri C, Petrungaro S, Galli R (2005) Characterization of signaling pathways leading to Fas expresión induced by TNF-a: pivotal role of NF-kB. FASEB J 19: 473-475 (Pubitemid 40316554)
45. Trubiani O, Recchioni R, Moroni F, Pizzicannella J, Caputi S, Diprimio R (2005) Melatonin provokes cell death in human B-lymphoma cells by mitochondrialdependent apoptotic pathway activation. J Pineal Res 39: 425-431
46. Uren A, Toretsky JA (2005) Ewing's's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent. Future Oncol 1: 521-528
47. Wolfler A, Caluba HC, Abuja PM, Dohr G, Schauenstein K, Liebmann PM (2001) Prooxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cells. FEBS Lett 502: 127-131 (Pubitemid 32728274)